23, 2024 — Researchers describe the steps they took to manipulate DNA and ... artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like ...

The company's balance sheet, with $1.9 billion in cash, means CRISPR has the time and capital to take the necessary steps to ...

Every investor in CRISPR Therapeutics AG ( NASDAQ:CRSP) should be aware of the most powerful shareholder groups. We can see that institutions own the lion's share in the company with 73% ownership.

The company's balance sheet, with $1.9 billion in cash, means CRISPR has the time and capital to take the necessary steps to become commercially sustainable. On the other hand, the latest ...

Read about how Crispr's robust pipeline for cardiovascular diseases holds blockbuster potential, with top-line results ...